Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105

Clinical trial NCT05289726 · UNKNOWN

Trial details

NCT number: NCT05289726
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hand and Foot Skin Reaction Colorectal Cancer Stage IV

Start date: 2022-04-18
Primary completion: 2022-07-18
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.